GLP-1 receptor agonists were associated with markedly lower risks of major adverse cardiovascular events, progression of kidney disease, venous thromboembolism, and all-cause mortality compared to DPP-4 inhibitor therapy
CJC-1295 comes in two forms: with DAC (long-acting, 8-day half-life) and without DAC (short-acting, also called Modified GRF 1-29)
Stay hydrated, rest, and eat smaller, bland meals if hunger returns
10 The inclusion criteria was identical for both trials and baseline characteristics for body weight, BMI, and waist circumference were very similar across all participants
Key mechanisms include the relief of hypothalamic-pituitary-ovarian (HPO) axis inhibition through weight loss and improved insulin sensitivity, alongside improved endometrial receptivity driven by increased SHBG and decreased free androgens (83, 167, 168)